更正：S100A6是造血干细胞的关键调节因子。
Correction: S100A6 is a critical regulator of hematopoietic stem cells.
作者信息
Grahn Tan Hooi Min, Niroula Abhishek, Végvári Ákos, Oburoglu Leal, Pertesi Maroulio, Warsi Sarah, Safi Fatemeh, Miharada Natsumi, Capellera-Garcia Sandra, Siva Kavitha, Liu Yang, Rörby Emma, Nilsson Björn, Zubarev Roman A, Karlsson Stefan
机构信息
Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, 22184, Lund, Sweden.
Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13,, SE-221 84, Lund, Sweden.
出版信息
Leukemia. 2020 Dec;34(12):3439. doi: 10.1038/s41375-020-0971-1.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
本文的一个修订版本已发表，可通过本文顶部的链接获取。
相似文献
1
Correction: S100A6 is a critical regulator of hematopoietic stem cells.更正：S100A6是造血干细胞的关键调节因子。
Leukemia. 2020 Dec;34(12):3439. doi: 10.1038/s41375-020-0971-1.
2
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.作者更正：长期造血干细胞中X连锁重症联合免疫缺陷病（SCID-X1）的基因校正。
Nat Commun. 2019 Dec 4;10(1):5624. doi: 10.1038/s41467-019-13620-5.
3
Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.更正：表达血小板衍生生长因子B的间充质干细胞可改善免疫缺陷小鼠中人类造血干细胞的植入。
Bone Marrow Transplant. 2020 Jun;55(6):1211-1212. doi: 10.1038/s41409-020-0781-0.
4
Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment.修正：尽管造血干细胞中存在突变获得现象，但青少年髓单核细胞白血病增殖细胞并不总是局限于这一细胞区室。
Leukemia. 2020 Jul;34(7):1973. doi: 10.1038/s41375-020-0720-5.
5
Correction: Premature ageing following allogeneic hematopoietic stem cell transplantation.更正：异基因造血干细胞移植后的早衰。
Bone Marrow Transplant. 2020 Jul;55(7):1519. doi: 10.1038/s41409-020-0900-y.
6
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins.作者更正：用于治疗性蛋白质红系表达的人造血干细胞的体外编辑。
Nat Commun. 2020 Aug 13;11(1):4146. doi: 10.1038/s41467-020-18036-0.
7
Author Correction: Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing.作者更正：利用基因组编辑技术在人类造血干细胞中构建单核细胞/巨噬细胞特异性葡萄糖脑苷脂酶表达
Nat Commun. 2020 Aug 20;11(1):4231. doi: 10.1038/s41467-020-18044-0.
8
Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial.更正：儿童急性髓系白血病造血干细胞移植——AML SCT-BFM 2007试验结果
Leukemia. 2020 May;34(5):1486. doi: 10.1038/s41375-019-0648-9.
9
Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.更正：对于成人淋巴细胞淋巴瘤患者，异基因造血干细胞移植应优先于传统化疗作为缓解后治疗手段。
Bone Marrow Transplant. 2020 Oct;55(10):2056. doi: 10.1038/s41409-020-0962-x.
10
Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.更正：高分辨率HLA分型单倍型频率用于预测非亲缘供者检索成功率及造血干细胞移植后的临床结局
Bone Marrow Transplant. 2020 Jun;55(6):1215. doi: 10.1038/s41409-020-0862-0.
引用本文的文献
1
S100A6 as a Constituent and Potential Marker of Adult and Cancer Stem Cells.S100A6 作为成体干细胞和肿瘤干细胞的组成部分和潜在标志物。
Stem Cell Rev Rep. 2022 Dec;18(8):2699-2708. doi: 10.1007/s12015-022-10403-2. Epub 2022 Jul 7.
Zotero 插件